NCT05452265

Brief Summary

The investigators conducted a retrospective study of those patients with gastric SETs receiving ER or LR at the operative theater in the single institution from January 2013 to December 2021. Medical records were retrospectively reviewed to define patient/tumor characteristics and operative outcomes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
194

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 11, 2022

Completed
Last Updated

July 11, 2022

Status Verified

July 1, 2022

Enrollment Period

9 years

First QC Date

June 29, 2022

Last Update Submit

July 7, 2022

Conditions

Keywords

gastric subepithelial tumorsendoscopic resectionlaparoscopic resection

Outcome Measures

Primary Outcomes (3)

  • Procedure duration

    minutes of procedure time

    during the procedure/surgery

  • Length of hospital stay

    days of hospitalization

    upto one month after surgery

  • Rate of postoperative major complications

    complications required further intervention, clavien dindo classification upto Grade III

    upto one month after surgery

Study Arms (2)

endoscopic resection (ER)

ER with backup surgery was indicated for patients with endoscopic intent, and a small tumor size tolerated endoscopic retrieval.

Procedure: Endoscopic resection

laparoscopic resection (LR)

LR was indicated for patients with surgical intent, and those with the following conditions, which were not suitable for ER: (1) large tumor size with difficult endoscopic retrieval ; (2) symptoms of gastrointestinal tract bleeding with difficulty in endoscopic visualization; (3) suspicion of tumor rupture that required intra-abdominal exploration; and (4) histologic diagnosis of GIST with initial treatment of target therapy.

Interventions

Complete resection of gastric SETs was recommended if the tumor size was \>2 cm, presence of malignant features, or if the patient was symptomatic, declined periodical surveillance, and preferred to undergo diagnostic and therapeutic resection.

Also known as: Laparoscopic resection
endoscopic resection (ER)

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with gastric SETs who underwent ER or LR at the operative theater in our institution

You may qualify if:

  • patients with gastric subepithelial tumors
  • patients received minimal invasive surgery (endoscopy or laparoscopy) for tumor resection

You may not qualify if:

  • patients had gastric anatomic changes due to previous surgery
  • patients converted open surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Endoscopic Mucosal Resection

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2022

First Posted

July 11, 2022

Study Start

January 1, 2013

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

July 11, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share